CD274 and neoplasm: This can be explained by the fact that while ICIs aim to reverse the anergy or exhaustion of tumor-infiltrating cells (TILs), these are scarce in GBM and have lower expression of commonly targeted checkpoint receptors such as PD-1 and PD-L1.